Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
381.00    8.00 (2.14%)
Bid:
379.00
Ask:
400.00
Spread: 21.00 (5.541%)
Market Cap: £152.30m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Trading Statement

28 Jan 2025 07:00

RNS Number : 8663U
Dialight PLC
28 January 2025
 

FOR IMMEDIATE RELEASE

 

Dialight PLC

28 January 2025

 

Dialight plc ("Dialight" or the "Company")

Q3 trading update

&

Sanmina litigation - settlement discussions

 

Q3 trading update

Trading performance for the 3-month period ended 31 December 2024 was slightly ahead of our expectations. The business traded profitably and generated positive operating cash flow. Group net debt (excluding leases) at 31 December 2024 was $14.8m (30 September 2024: $15.4m). The Board remains confident that further progress will be made during the rest of the financial year.

 

The early Transformation Plan progress reported with the Interim Results in November continued to gain momentum in the third quarter which has allowed us to introduce our 5th Transformation Pillar of creating a platform for future growth. This will provide a strategy and innovation platform for future products and services that, together with the other four pillars, will provide a solid sales and operational base for future, profitable growth. We will also continue to explore opportunities to accelerate our Transformation Plan to focus on delivering our medium-term ambitions.

 

Sanmina litigation - settlement discussions

On 25 September 2024, Dialight announced the details of the jury verdict in the trial relating to the litigation with its former manufacturing partner, Sanmina Corporation (NASDAQ: SANM) (Sanmina) and confirmed that a definitive judgment would be handed down once certain post-trial motions had been filed. Those post-trial motions have now been filed.

 

The Company is pleased to announce that, following constructive discussions with Sanmina, agreement has now been reached in principle to resolve the dispute. Under the settlement terms, Dialight will pay Sanmina $12m in full and final settlement of all claims between the parties. This amount will be paid in instalments, with the first payment of $4m due by 31 March 2025, followed by 8 instalments (the Deferred Instalments) of $1m paid at the end of each subsequent calendar quarter through to 31 March 2027.

 

The amount of any outstanding Deferred Instalments will be automatically increased from $1m to $1.5m if Dialight's market capitalisation exceeds £100m for 30 consecutive days, subject to total cumulative instalment payments not exceeding $8m. A letter has been filed with the New York Southern District court requesting that judgment is deferred pending agreement on a final definitive settlement and the parties will work together to agree a final definitive settlement agreement.

 

The Board is confident that the initial payment of $4m and the Deferred Instalments totalling $8m will be met from the operational cashflow of the business and that the Group has sufficient headroom to meet its ongoing business needs. In the highly remote event of payment default under the settlement agreement following the initial payment, Sanmina will be entitled to enforce the full judgment (less payments already made) in the ordinary course following a 90-day cure period (1).

 

Steve Blair, Dialight CEO, commented: "I am pleased that we have been able to reach a settlement that allows us to put this long running issue behind us. I would particularly like to thank Jure Sola and Jon Faust of Sanmina for their openness and willingness to agree the settlement. Our focus remains on our Transformation Plan for Dialight, for the benefit of all our stakeholders."

 

Note 1: The full judgment, equating to the total claims by Sanmina (as previously disclosed), would amount to $22.9m comprising the jury award of $8.6m, interest of $6.3m and legal costs of $7m.

 

Contacts: 

 

Dialight plc

Tel: +44 (0)203 058 3542

Steve Blair, CEO

Mark Fryer, CFO

 

Investec Bank plc (Financial Adviser and Corporate Broker)

Tel: +44 (0)207 597 5970

Christopher Baird / James Rudd

 

 

Dialight plc

 

About Dialight:

Dialight (LSE: DIA.L) is a global leader in sustainable LED lighting for industrial applications. Dialight's LED products are providing the next generation of lighting solutions that deliver reduced energy consumption and create a safer working environment. Our products are specifically designed to provide superior operational performance, reliability and durability, reducing energy consumption and ongoing maintenance and achieving a rapid return on investment. The company is headquartered in the UK with operations in Australia, Dubai, Germany, Malaysia, Mexico, Singapore, the UK and the USA. www.dialight.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAFFXALNSEAA
Date   Source Headline
25th Sep 20245:03 pmRNSDirector/PDMR Shareholding
25th Sep 20247:00 amRNSSanmina Litigation
24th Sep 20247:00 amRNSSanmina Litigation
23rd Sep 202412:31 pmRNSResult of AGM
16th Sep 20247:00 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSDirector/PDMR Shareholding
19th Aug 202410:13 amRNSNotice of AGM
16th Aug 20246:10 pmRNSNotice of AGM
12th Aug 20247:00 amRNSDirector/PDMR Shareholding
1st Aug 20247:00 amRNSDirectorate Change
31st Jul 20243:27 pmRNSAnnual Financial Report
30th Jul 20247:00 amRNSFinal Results
29th Jul 20245:34 pmRNSChange of Registered Office
29th Jul 20247:00 amRNSNon-core disposal
23rd Jul 20247:30 amRNSSanmina Litigation
13th Jun 20247:00 amRNSUpdate Announcement
7th May 20247:00 amRNSTotal Voting Rights
19th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 202411:00 amRNSAdmission of New Shares
12th Mar 20245:55 pmRNSHolding(s) in Company
12th Mar 20244:56 pmRNSHolding(s) in Company
26th Feb 20242:39 pmRNSDirector/PDMR Shareholding
19th Feb 20249:16 amRNSDirectorate Change
19th Feb 20247:00 amRNSStatement re second interim results
16th Feb 20247:00 amRNSDirectorate Change
30th Jan 20247:00 amRNSCFO Appointment
30th Jan 20247:00 amRNSTrading Update
2nd Jan 20247:00 amRNSSanmina Litigation
29th Nov 20231:04 pmRNSSanmina Litigation
7th Nov 20235:40 pmRNSHolding(s) in Company
7th Nov 20235:24 pmRNSHolding(s) in Company
7th Nov 20233:52 pmRNSHolding(s) in Company
1st Nov 202312:03 pmRNSPDMR Shareholding
1st Nov 202311:50 amRNSTotal Voting Rights and Capital
1st Nov 202311:15 amRNSBlock listing Interim Review
31st Oct 20234:32 pmRNSHolding(s) in Company
27th Oct 202312:05 pmRNSResults of General Meeting
4th Oct 202311:52 amRNSCirc re. Related Party Transaction
27th Sep 20237:00 amRNSResult of Equity Issue
26th Sep 20235:07 pmRNSREX Retail Offer
26th Sep 20235:05 pmRNSProposed Placing and Retail Offer
18th Sep 202312:25 pmRNSStatement re Update on Financing
18th Sep 20237:00 amRNSDirector Change
18th Sep 20237:00 amRNSUnaudited Half Year Results 2023
26th Jun 20237:00 amRNSDirectorate Change and Notice of Results
8th Jun 20237:00 amRNSDirector/PDMR Shareholding
7th Jun 20237:00 amRNSDirectorate Changes
16th May 20235:47 pmRNSResult of AGM
16th May 20237:00 amRNSAGM Trading Update
27th Apr 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.